Aung TH. Proximicin A-C as prospective HER2-positive and negative breast cancer drugs: Molecular docking and in silico ADME modeling. J. Comput. Drug Des. Mol. Simu [Internet]. 2022 May 18 [cited 2026 Jun. 3];1(1):1-11. Available from: https://journals.ipsintelligentsia.com/drugdiscoveryupdate/index.php/jcddms/article/view/9